Prognostic exploration of OC mainly focuses on genomics, in addition to proteomics, immunology, cytokines and other aspects, among which there are complex relationships.For example, the tumor suppressor genes BRCA1 and BRCA2, whose mutations undergo a large number of splicing events, are important components of inherited breast and OC [20–22]. The gene discussed is BRCA1; the disease is neoplasm.